Pharmaceuticals(50)
-
Universal CAR-Ts for Treating Cancer (No. T4-1884)
Chimeric Antigen Receptor T-Cells (CAR-Ts) are one of the revolutionary technologies of the twenty-first century, invented by Prof. Zelig Eshhar at the Weizmann Institute of Science. ... Read moreZelig Eshhar
Faculty of Biology5722 -
Covalent Inhibitors for Treatment of Inflammation and Neurodegeneration (No. T4-1880)
C-Jun NH2-terminal kinase (JNK) plays an integral role in many cellular processes and is associated with the pathophysiology of a number of neurological, inflammatory, and autoimmune diseases. ... Read more6109 -
Treatment of Psychiatric Disorders by Inhibiting Importin Alpha 5 (No. T4-1875)
Anxiety and stress-related conditions pose a significant health burden on modern healthcare systems. While currently, available anxiolytic drugs can be highly effective for some patients, their long-term use is limited by their potentially severe and debilitating side effects. The group of Prof. ... Read more5719 -
Targeting Novel Regulator for Improved Hematopoietic Stem Cells Generation (No. T4-1874)
A potential method of generating hematopoietic stem cells for transplantation by inhibiting CD74. ... Read more5716 -
Allogeneic Cell Transplantation for Treatment for Lung Diseases (No. T4-1868)
The treatment of respiratory conditions is currently one of the major challenges to health care systems all over the world. The problem is that most therapeutics currently available for treating pulmonary indications are non-curative, and simply improve symptoms. ... Read moreYair Reisner
Faculty of Biology5707 -
Detecting Necroptosis Activation via Exosome Analysis (No. T4-1839)
Numerous medical conditions are related to inflammation, such as pancreatitis, psoriasis, inflammatory bowel disease, atherosclerosis, neurodegeneration, and more. However, determination of inflammation in the body, especially at early stages of a pathology is difficult to assess. ... Read more5680 -
Method for Microbiome-Based Prediction, Diagnosis, and Treatment of Relapsing Obesity (No. T4-1805)
A novel method for analyzing the likelihood of weight regain following a weight loss program and maintaining target body weight, based on gut microbiome analysis. ... Read more5659 -
Method for Microbiome-Based Prediction, Diagnosis, and Treatment of Relapsing Obesity (No. T4-1805)
A novel method for analyzing the likelihood of weight regain following a weight loss program and maintaining target body weight, based on gut microbiome analysis. ... Read more5659 -
Antibody for Preventing/Treating Secondary Respiratory Infections (No. T4-1790)
A novel method of preventing secondary infections, by inhibition of membrane type I matrix-metalloproteinase-1, which reduces degradation of the extra cellular matrix. ... Read more5647 -
Antibody for Preventing/Treating Secondary Respiratory Infections (No. T4-1790)
A novel method of preventing secondary infections, by inhibition of membrane type I matrix-metalloproteinase-1, which reduces degradation of the extra cellular matrix. ... Read more5647
Pages
